dailystar.co.uk
89%
341
Antibody drug Evusheld approved to prevent Covid in people with weak immune systems
drug named Evusheld has been approved to prevent Covid in people with weak immune systems, the government has confirmed.Evusheld was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) today ( March 17), after meeting the UK regulatory standards of safety, quality and effectiveness.The drug, which was developed by AstraZeneca, was accepted for treatment after being endorsed by the government’s independent expert scientific advisory body, the Commission on Human Medicines.Evusheld is a combination of two long-acting antibodies that works by binding to the spike protein on the outside of the SARS-CoV-2 virus, the virus that causes Covid-19. This in turn stops the disease from fixing to and entering human cells.The new medicine is permitted to be used before being exposed to the risk of Covid-19 infection in order to prevent disease.